Skip to main content
Premium Trial:

Request an Annual Quote

Luminex Racks Up 25th Partnership in Deal with Biosource

NEW YORK, Dec 18 – Luminex said Monday it has signed an agreement with immunoassay maker Biosource International to jointly develop assay and reagent kits using Luminex’s Labmap technology.

Under terms of the agreement, Luminex has received an advance on royalties from the sale of the assays. BioSource, Luminex's 25th partner, will begin marketing the new assay panels using the LabMap technologies beginning early next year.  

The LabMap technology uses microspheres, small lasers, digital processors, and software to perform up to 100 assays per drop of fluid. Biosource is planning to use this technology to develop assays that detect post-translational modification of proteins in order to understand the underlying mechanics of disease processes.   

Biosource will combine this with its signal transduction, cytokine, immunology, and neuroscience kits.

" BioSource's unique assay capabilities in the areas of cytokines, signal transduction and immunology, combined with our proprietary technology, will strengthen both companies' positions in the marketplace,” John Porter, Luminex's director of business development, said in a statement.

 

 

Luminex’ business strategy focuses on developing partnerships with outside companies to commercialize its technology. Bio-Rad, Hitachi, Qiagen, and Upstate Technology have also recently signed on as partners.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.